Glen Eagle Advisors, LLC
- SEC CIK
- 0002029317
- Latest filing
- Aug 14, 2026
ROIV holding history
Roivant Sciences Ltd. in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ROIV overviewAll 13F holders of ROIVFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −435−100.0% | Sold out | Holders |
| Q2 2025 | 435 | $4.90K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 435 | $4.39K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 435 | $5.15K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 435 | $5.02K | <0.1% | +435 | New | Holders |